Daily Daily foreign exchange rates for our top 10 currencies & Update #forex #Vancouver April 29, 2019

USDCAD spot rate: 1.3460 - 1.3465 (as at 8:00am PST)

Technical Support / Resistance:

Key Economic Data Releases:

- U.S. PCE price index: 0.1% (exp 0.0% / prev -0.1%)

- U.S. personal income: 0.1% (exp 0.4% / prev 0.2%)

- U.S. personal spending: 0.9% (exp 0.7% / prev 0.1%)

Event Calendar:

U.S. stocks rose above their record high at the start of a week packed with data that will provide clues on global economic growth. Treasury yields and the dollar climbed, while oil fell. Financial and industrial companies led gains in the S&P 500 Index. The Stoxx Europe 600 Index fluctuated as data showed euro-area economic confidence at a two-year low. Crude extended losses after U.S. President Donald Trump renewed his push for lower prices and Russia said it would soon resolve a problem with contaminated supplies. Policy makers are expected to hold rates steady on Wednesday, though new growth and prices data may affect their characterization of the economy. The next round of China-U.S. trade talks will get under way this week with significant issues still unresolved but with enforcement mechanisms "close to done," U.S. Treasury Secretary Steven Mnuchin said. Elsewhere, Spain's benchmark stock index underperformed as Socialist Pedro Sanchez looked set to return as the country's prime minister after snap elections. Markets in Japan remained shut for holidays, with many others set to follow suit on May 1. Currently, the TSX is up 0.2% and the DJIA is up 0.07%. EURCAD is up 0.22% trading between 1.4986 and 1.5040. GBPCAD is up 0.06% trading between 1.7370 and 1.7437. JPYCAD is down 0.09% trading between 0.01203 and 0.01206. Gold is down 0.50% trading between $1,278 and $1,286USD/oz, silver is down 0.83% trading between $14.88 and $15.07USD/oz, while oil (WTI crude) is down 0.39% trading between $62.47 and $63.28.

Sources: Reuters, Bloomberg, FXStreet, RBC Capital Markets, Bank of Canada, U.S. Federal Reserve, CNBC, Forexlive, CME Group